Hims & Hers Health revenue and financials
$29.47Change from previous close: 0.00%
In the fiscal year ended December 2025, Hims & Hers Health reported revenue of $2.35B (+59.00% year over year). Net income was $128.37M, a net margin of 5.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +59.00%
- 2025 vs 2024
- Net income growth
- +1.85%
- 2025 vs 2024
- Net margin
- 5.5%
- 2024: 8.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 2,348 | 1,477 | 872 | 527 | 272 |
| Cost of revenue | 614 | 303 | 157 | 118 | 67.4 |
| Gross profit | 1,733 | 1,173 | 715 | 409 | 204 |
| Selling, general and administrative | 1,463 | 1,028 | 693 | 446 | 289 |
| Research and development | 149 | 78.8 | 48.2 | 29.2 | 22.4 |
| Operating income | 121 | 65.9 | -26.4 | -66.4 | -107 |
| EBIT | 121 | 65.9 | -26.4 | -66.4 | -107 |
| EBITDA | 176 | 83.0 | -16.9 | -58.9 | -103 |
| Interest expense | 3.9 | — | — | — | 0.0 |
| Pre-tax income | 124 | 71.7 | -21.6 | -65.7 | -111 |
| Income tax | -4.4 | -54.3 | 2.0 | -0.0 | -3.1 |
| Net income | 128 | 126 | -23.5 | -65.7 | -108 |
| Net income to common shareholders | 128 | 126 | -23.5 | -65.7 | -108 |
| Basic EPS | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 |
| Diluted EPS | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 |
| Average shares (basic) | 225 | 216 | 209 | 205 | 187 |
| Average shares (diluted) | 258 | 237 | 209 | 205 | 187 |